THG PLC
07 August 2026
7 August 2026
THG PLC
(the "Company")
Capital Reduction Becomes Effective
The Company is pleased to announce that, pursuant to an order issued by the High Court of Justice in England and Wales (the "Court") for the cancellation of the Company's share premium account and capital redemption reserve (the "Capital Reduction") on 28 July 2026, the order of the Court confirming the Capital Reduction, and a statement of capital approved by the Court, were duly registered by the Registrar of Companies. Accordingly, the Capital Reduction has now become effective.
Details of the Capital Reduction, which was approved by shareholders on 24 June 2026, were set out in the Notice of annual general meeting published on 22 May 2026. The Capital Reduction does not involve any distribution or payment of capital by the Company.
For further information please contact:
|
Investor enquiries - THG PLC:
|
|
|
Jordan Foster, Deputy CFO |
|
|
Media enquiries: |
|
|
Sodali & Co - Financial PR adviser |
Tel: +44 (0) 20 7250 1446 |
|
Victoria Palmer-Moore/Russ Lynch/Sam Austrums |
|
|
THG PLC |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.